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Abstract
Background Previous studies have investigated weight loss caused by exercise following bariatric surgery. However, in most
cases, the training program is poorly reported; the exercise type, volume, and intensity are briefly mentioned; and the sample size,
selection criteria, and follow-up time vary greatly across studies.
Purpose The EFIBAR study aims to investigate over 1 year the effects of a 16-week supervised exercise program, initiated
immediately after bariatric surgery, on weight loss (primary outcome), body composition, cardiometabolic risk, physical fitness,
and quality of life in patients with severe/extreme obesity.
Material and Methods The EFIBAR study is a parallel-group, superiority, randomized controlled trial (RCT), comprising 80
surgery patients. Half of the participants, randomly selected, perform a 16-week supervised exercise program, including both
strength and aerobic training, starting immediately after the surgery (7–14 days). For each participant, all primary and secondary
outcomes are measured at three different time points: (i) before the surgery, (ii) after the intervention (≈4 months), and (iii) 1 year
after the surgery.
Key Points
• Exercise programs following bariatric surgery are, in most cases, poorly
reported.
• EFIBAR study includes 80 patients and a 16-week supervised exercise
program, starting 7–14 days after the surgery.
• Multiple health-related outcomes are assessed before surgery, at 4
months, and 1 year.
• This RCTwill contribute to understand the effectiveness of exercise as a
therapeutic complement to bariatric surgery.
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Conclusion The EFIBAR study will provide new insights into the multidimensional benefits of exercise in adults with severe/
extreme obesity following bariatric surgery.
Trial Registration EFIBAR randomized controlled trial was prospectively registered at Clinicaltrials.gov (NCT03497546) on
April 13, 2018.
Keywords Obesity . Bariatric surgery . Exercise . Randomized controlled trial (RCT) . Protocol
Introduction
Bariatric surgery is an effective treatment option for reducing
weight in people with extreme obesity [1], on average losing
around 12% of total body weight in the first 6 months and up to
45% over 3 years [2]. Physical activity (PA) and exercise re-
duce comorbidities related to obesity, such as asthma and sleep
problems [3], insulin resistance, hypertension, and hypercho-
lesterolemia [4]. Furthermore, exercise plays an important role
in the amount of weight regained following weight loss and
helps to reduce weight progressively [5]. Given the increasing
number of people with extreme obesity [6], the proven short-
and long-term effectiveness of bariatric surgery [7], and the
possibilities presented by exercise in relation to the mainte-
nance and improvement of risk factors [8], PA could help those
patients who suffer weight regain after bariatric surgery [9].
Previous studies have investigated weight loss caused by ex-
ercise following bariatric surgery, generally suggesting the suit-
ability of PA for improving bariatric surgery outcomes [10–12].
However, in many cases, the training program is poorly reported
[13]; the exercise type, volume, and intensity are briefly men-
tioned; and the sample size, selection criteria, and follow-up time
vary greatly across studies [14]. The EFIBAR randomized con-
trolled trial (Ejercicio FÍsico tras cirugía BARiátrica, Physical
Exercise after Bariatric Surgery) aims to investigate over 1 year
the effects of a 16-week supervised exercise program, initiated
immediately after bariatric surgery, on weight loss, body compo-
sition, cardiometabolic risk, physical fitness, and quality of life in
patients with severe/extreme obesity. Even if additional weight
loss is not achieved [14], exercise following bariatric surgery
may help to maintain lean body mass, improve cardiovascular
health and psychological well-being, and increase adherence to
PA, among other benefits [9]. The results of this study may help
to assess the effectiveness of exercise as a therapeutic comple-
ment to bariatric surgery.
Materials and Methods
Study Design, Protocol Registration, and Reporting
The EFIBAR study is a parallel-group, superiority, random-
ized controlled trial (RCT) registered at www.clinicaltrials.
gov (NCT03497546) on April 13, 2018, before the enrollment
of participants began (May 1, 2018). The design of the study,
as well as this protocol manuscript, follows the SPIRIT
reporting guideline [15].
Recruitment and Eligibility Criteria
Recruitment
The recruitment process takes place through the Bariatric
Surgery Units of Torrecárdenas University Hospital and
Hospital Mediterráneo, both located in the city of Almería
(Spain). In both centers, the surgical team includes surgeons
accredited by the Spanish Society for Obesity and Metabolic
Surgery (SECO), performing the interventions under the same
criteria.
Eligibility Criteria
The participants’ inclusion and exclusion criteria are listed in
Table 1.
Sample Size
Assuming an alpha error of 0.05 and a power of 80%, a total of
66 patients (n=33 patients per group) are needed to detect an
effect (between group difference) of at least 0.7 standard de-
viations [16] in the % of total weight loss (% TWL).
Anticipating a potential follow-up loss of up to 20%, a total
of 80 patients will be recruited (i.e., 40 per group). Based on
previous literature and our surgical team’s experience, 60–
80% of the recruited participants are expected to be women.
Randomization
Participants are randomly assigned to the experimental (EG) or
control group (CG).Amember of our research team (statistician),
not involved in any other section of the study, created a
computer-generated sequence of simple randomization [17].
The sequence is concealed using sealed and opaque envelopes
numbered sequentially. Only patients who meet all the selection
criteria, sign an informed consent, and finally undergo the sur-
gery receive a randomization number, corresponding to the
OBES SURG
allocation sequence previously generated. After the surgery, at
medical discharge, a nurse opens the envelope in front of the
patient, in the absence of any blinded member of the research
team.
Blinding
Because of the type of intervention (exercise program), it is not
possible to mask either the patients or the surgeon, given that
participants inevitably reveal the group allocation during postop-
erative follow-up consultations. However, researchers responsi-
ble for evaluation and data analysis are blinded to the group
assignment (blind evaluator and blind data analyst, respective-
ly). In addition, personal trainers in charge of implementing the
exercise program are not part of the assessment team.
Data collection
Assessment Protocol
Each participant receives three complete clinical assessments
over the study: (1) pre-surgery evaluation, 5–12 days before
the surgery; (2) post-intervention evaluation, 5–10 days after
completing the intervention phase (i.e., approximately 4
Table 1 Eligibility criteria
Inclusion criteria Exclusion criteria
Age 18-60 yrs. Severe psychiatric or neurological disorders such as schizophrenia, epilepsy,
Alzheimer’s, Parkinson’s, personality disorders, eating behavior disorders,
untreated depression, or suicidal tendencies
BMI ≥ 40 kg/m2 (or ≥ 35 kg/m2 with comorbid conditions)
Acceptable surgical risk (defined by the approval of an anesthetist)
Obesity maintained for over 5 years Adrenal or thyroid pathology that might cause obesity
Failure of previous treatments
Not presenting contraindications for supervised physical exercise Uncontrolled addiction to alcohol or drugs
To reside in the city of Almería (or willingness/predisposition to
attend the training sessions 3 times a week over 16 weeks)
















Weight loss x x x x x x x
Secondary outcomes
Body compositiona x x x
CVD risk biomarkersb x x x
Central and brachial BP, resting HR, PWV x x x
HRV x x x
Health-related fitness and physical activity c x x x
Health-related quality of life (SF-36v2) x x x
Health-related quality of life (EQ-5D) x x x x x x x
Symptomatology and function of hip/knee osteoarthritis
(WOMAC)
x x x
Depression, anxiety, and stress (DASS-21) x x x
Emotional, psychological, and social well-being
(MHC-SF)
x x x
BP blood pressure (mm/Hg),CVD cardiovascular diseases,DASS-21Depression, Anxiety and Stress Scale short form, EQ-5D European Quality of Life-
5 Dimensions,HR heart rate (bpm),HRV heart rate variability,MHC-SFMental Health Continuum-Short Form, PWV pulse wave velocity (m/seg), SF-
36v2 36-item Short-Form Health Survey, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index
a Body fat (%), fat mass (kg), fat-free mass (kg), body mass index (BMI; kg/m2 ), waist and hip circumferences (cm)
b Total cholesterol (mg/dl), HDL-cholesterol (mg/dl), LDL-cholesterol (mg/dl), triglycerides (mg/dl), glucose (mg/dl), insulin (μUI/ml), glycated
hemoglobin HbA1c (%), insulin resistance [homeostasis model assessment, (HOMA-I)], high-sensitivity C-reactive protein [hs-CRP, (mg/dl)], tumor
necrosis factor [TNF-alpha (pg/ml)], interleukin 6 [IL-6, (pg/ml)], alanine aminotransferase (ALT, U/L), aspartate aminotransferase (AST, U/L) and
alkaline phosphatase (ALP, U/L)
c Cardiorespiratory fitness (VO2max, METs), hand-grip strength (kg), 30-s chair-stand test (number of repetitions), back scratch test (cm), and objectively
measured physical activity (accelerometry)
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months after the surgery); and (3) follow-up evaluation, 1 year
after the surgery (Figure 1).
Primary Outcome
The percentage of total weight loss (%TWL) has been recom-
mended for expressing weight loss after surgery [18, 19]: %
TWL = [(pre-surgery weight – post-surgery weight)/(pre-sur-
gery weight)] × 100. In the EFIBAR study, weight is mea-
sured using a bioimpedance device (InBody 270, Biospace
Co., USA).
Secondary Outcomes
1. Body composition. Electric bioimpedance (InBody 270,
Biospace Co., USA; Lookin’Body 120 software) is used
to measure fat mass (FM, kg), fat-free mass (FFM, kg), and
percentage of body fat (%BF). All participants are asked to
urinate before the assessment, and to fast for at least 2h.
Height is measured using a portable system (SECA 213,
Hamburg, Germany) with the patient shoeless in a standing
position. Body mass index (BMI) is calculated as weight
(kg) divided by height squared (m2).Waist and hip circum-
ferences are measured in cm with an anthropometric tape,
following standardized guidelines [20].
2. Cardiovascular diseases risk biomarkers. Fasting blood
samples are collected and processed by the Sistema
Sanitario Público de Andalucía (SSPA) Biobank, accord-
ing to standard procedures: (2.1) lipid profile: total cho-
lesterol (mg/dl), HDL-cholesterol (mg/dl), LDL-
cholesterol (mg/dl), and triglycerides (mg/dl); (2.2) glyce-
mic control: glucose (mg/dl), insulin (μUI/ml), glycated
hemoglobin HbA1c (%), and insulin resistance (homeo-
stasis model assessment, (HOMA-I), [21]); (2.3) chronic
inflammation: high-sensitivity C-reactive protein [hs-
CRP, (mg/dl)], tumor necrosis factor alpha [TNF-alpha
(pg/ml)] and interleukin 6 [IL-6, (pg/ml)]; (2.4) liver me-
tabolism enzymes: alanine aminotransferase (ALT, U/L),
aspartate aminotransferase (AST, U/L), and alkaline
phosphatase (ALP, U/L).
3. Blood pressure and arterial stiffness: brachial and central
blood pressures (mm/Hg), resting heart rate (HR, bpm)
and arterial stiffness [pulse wave velocity, PWV
(m/seg)] are measured using a Mobil-O-Graph®
oscillometry-based pulse analysis system (IEM GmbH,
Stolberg, Germany) [22, 23]. Three readings are recorded
with the participant resting quietly in a sitting position for
10 min, the cuff placed on the upper left arm around the
brachial artery, and the palm facing upwards.
4. Heart-rate variability (HRV). Measurements take
place in the morning between 8:30 AM and 11:30
AM in a quiet, temperature-controlled room (22–
24°C). Participants are requested not to exercise or
to drink caffeinated and/or alcoholic beverages for
24 h prior to the examination and to fast for at least
3 h. Participants are instructed to breathe normally
and not to talk or fidget while measurements are
being taken. Duration of RR intervals is recorded
using a Polar V800 telemetry heart-rate monitor
(Polar Electro Oy, Kempele, Finland). The electrode
belt is dampened and placed just below the chest
muscles. Heart rhythm is recorded over 10 min at a
sampling frequency of 1000 Hz with the patient
seated. Kubios Premium software (v.3.2, Heart Rate
Analysis, University of Eastern Finland) is used to
process the raw HRV data [24, 25].
5. Health-related fitness (HRF) and physical activity (PA).
(5.1) Cardiorespiratory fitness is assessed using a
Figure 1 Data collection diagram.
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maximal treadmill test following the Bruce protocol [26,
27]. Maximal oxygen uptake (VO2max) in METs is esti-
mated based on time to exhaustion. Rate of perceived
exertion (RPE, Borg1–10 scale), maximum HR (bpm), and
recovery HR (1, 2, and 3 min afterwards, bpm) are also
recorded. (5.2) Hand-grip strength (kg) is measured using
a digital hand dynamometer (T.K.K. 5401 Grip-D; Takei,
Tokyo, Japan). The patient stands with the shoulder
slightly abducted (~10°), the elbow extended, and the
forearm and wrist in a neutral position. Each participant
performs the test three times (alternately with both hands)
allowing a 1-min rest betweenmeasurements. Grip span is
adapted to hand size differently for men and women [28].
(5.3) Lower body muscular strength: 30-s chair stand test.
This measures the number of full stand-ups from a seated
position that participants can complete in 30 s with arms
folded across chest [29]. (5.4) Upper body (shoulder) flex-
ibility: back scratch test (cm). With one hand reaching
over the shoulder and one up the middle of the back, the
number of centimeters between the extended middle fin-
gers is recorded (plus or minus). The best of two trials is
used for analysis [29]. (5.5) Objectively measured PA and
sedentary time are assessed by accelerometry (ActiGraph;
ActiLife version 6.11.7 software) [30, 31]. Patients wear a
triaxial accelerometer on the hip for 24 h (except for bath-
ing or water activities) that records acceleration in all three
movement axes (in min/day) of PA performed over a total
of 7 days. The information is collected over a 60-s period
at a sampling rate of 30 Hz [30]. The criterion for consid-
ering a record valid is to fulfill a minimum of 10 h a day
for 4 days [30].
6. Patient-reported outcomes. (6.1) Health-related quality of
life is assessed using the Spanish version of the 36-item
Short-Form Health Survey (SF-36v2) [32], together with
the European Quality of Life-5 Dimensions (EQ-5D)
[33]. (6.2) Symptomatology and function of hip/knee os-
teoarthritis is measured using the WOMAC (Western
Ontario and McMaster Universities) Osteoarthritis Index
[34, 35]. (6.3) Depression, anxiety and stress are assessed
using the Depression, Anxiety and Stress Scale short form
(DASS-21) [36]. (6.4) Emotional, psychological, and so-
cial well-being are measured using the Mental Health
Continuum-Short Form (MHC-SF) [37].
7. Cost-effectiveness analysis (CEA) and cost-utility analy-
sis (CUA). The costs of the two treatments under consid-
eration (bariatric surgery and bariatric surgery plus exer-
cise) will be investigated from a dual perspective: the
National Health Service and the patient. The first ap-
proach will consider the surgery, exercise program, pre-
scription medication, sick leave, postoperative complica-
tions, and readmission rates. The patient-centered ap-
proach will additionally include the time and effort requir-
ing each treatment, as well as any possible dietary and
informal care costs. Effectiveness will be evaluated in
terms of changes observed in the main clinical outcomes,
i.e., weight loss and cardiometabolic risk. On the other
hand, utility will be evaluated as variation in quality of
life experienced by participants (quality-adjusted life
years, QALY), using SF-36 and EQ-5D questionnaires.
All primary and secondary outcomes are shown in
Table 2.
Control Variables and Other Parameters to Be Recorded
Different variables are recorded that may influence the study
results even though they are not part of the intervention: (1)
sex, age, educational level, marital status, occupational status,
and income level; (2) personal history of obesity (obesity du-
ration), cardiovascular disease, hypertension, obstructive
sleep apnea (OSA), type 2 diabetes, and medication use; (3)
surgical technique (see below); (4.1) adherence to
Mediterranean diet [38, 39]; and (4.2) usual intake estimates
of food groups, energy, and nutrients using a self-
administered semi-quantitative food-frequency questionnaire
(FFQ) [40] and 24-h recalls.
Intervention
Bariatric Surgery
Three different techniques are used in this study, all of them
carried out using laparoscopic surgery: sleeve gastrectomy
(SG), gastric bypass (GB), and one anastomosis gastric bypass
(OAGB). The technique used for each participant is decided
by a multidisciplinary team of endocrinologists, nutritionists,
psychologists, and surgeons, based on patient’s BMI, comor-
bidities, and age, among other considerations. The distribution
of the three procedures (SG, GB, and OAGB) is expected to
be the same in the two groups (control vs. experimental).
Control Group (CG, Usual Care)
Participants in both groups receive the postoperative follow-
up routinely prescribed in both medical centers, according to
international standards [41]. During the first 4 weeks, all pa-
tients maintain a semi-liquid diet. Medical consultations are
scheduled at months 1, 3, 6, 9, and 12 after the surgery, with
special attention to nutritional status. Written counseling is
given, focused on the benefits of a healthy diet and regular
physical activity.
Experimental Group (EG, Usual Care + Supervised Exercise)
The EFIBAR training program has been published elsewhere
[42] and was designed and reported following the CERT
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guidelines [43]. The program begins 7–14 days after surgery,
exercising 3 times a week over 16 weeks (first 4 weeks of
familiarization), using 60-min sessions that includes (1) warm
up [light aerobic activity at 50–65% of HR reserve (HRR)],
(2) compensatory training (i.e., core stability and stabilizer
muscle exercises), (3) strength training (whole body exercises
progressing from 1 to 3 sets, from 12 to 6 repetitions per set,
from 24 to 10 repetitions maximum (RM) (≈50 to 75% of
1RM), (4) aerobic training (on a treadmill, progressing from
15 to 25 min, from 65 to 85% of HRR), and (5) cool down
(static and dynamic stretching exercises) [42] (Figure 2).
MaximumHR is recorded during the maximum treadmill test,
while resting HR is taken from the HRV assessment, both
included in the pre-surgery evaluations. Resting HR is re-
assessed twice throughout the program (sessions 12th and
36th), and the corresponding aerobic training zones are prop-
erly re-calculated. Two members of the research team, with
BSc degrees in Sport Sciences and at least 2 years of experi-
ence as personal trainers, are in charge of implementing the
exercise program. This is performed individually and super-
vised, with a 1:1 ratio unless participants report schedule un-
availability (allowing, in this case, two patients with the same
personal trainer) [42]. Attendance, punctuality, training HR,
rate of perceived exertion (RPE and ONMI), mood, adverse
events, and extra physical activity, among others, are recorded
daily. Performing at least 80% of all planned training sessions
will be considered a successful attendance rate. WhatsApp
messages and videos are sent to participants every Friday
and every month, respectively, to encourage adherence
throughout the intervention [42].
Statistical Analysis
To test whether the randomization has worked effectively,
baseline values will be compared for potential clinically im-
portant differences. The difference between groups in the
change (post-pre) in % TWL (primary outcome) and all sec-
ondary outcomes will be analyzed using the generalized linear
model, with the post-pre difference as the dependent variable,
and the group (EG or CG), time (16 weeks or 12 months), and
their interaction, as the fixed effects. The effect size (95%
confidence interval) and statistical significance will be report-
ed for the effects of group (between-subjects), time (intra-sub-
ject), and the group × time interaction. The primary analysis
will follow per-protocol analysis (only including participants
with available data who attend at least 80% of the exercise
sessions). Sensitivity analyses will be performed using the
intention-to-treat (ITT) principle. For that purpose, any miss-
ing data will be replaced through multiple imputations using
regression models with age, type of surgical technique, and
baseline values as predictors. The analyses will be adjusted for
baseline values plus relevant confounding variables. Stata
v.13.1 or higher (StataCorp LP, College Station, TX) will be
used to conduct the analyses, and the statistical significance
will be set at P <.05.
Discussion
Obesity is certainly one of the most serious and prevalent
health problems currently challenging our society. In less than
5 years (by 2025), obesity is expected to reach a global prev-
alence of 20%, with almost half of that corresponding to
severe/extreme obesity [44]. The burden that this group of
patients poses to the health and economic systems is remark-
able [45], as a direct result of the treatment costs (usually long-
term) but also because of the interruption of their contribution
to the production system. Any strategy that can improve their
prognosis and allow them to return to society with recovered
functional capacity will have a huge impact, not just on them
but also on their communities, leading to increased quality of
life, productivity, and economic growth.
Our study will primarily investigate whether weight loss 1
year after surgery is greater among those who followed the
exercise program. More interestingly, we will be able to test
whether this exercise program can mitigate the decrease in
muscle mass that normally accompanies bariatric surgery
[46]. In addition, this study includes multiple health-related
outcomes other than weight loss and body composition, such
as lipid and glycemic profiles, chronic inflammation, liver
biomarkers, physical fitness, PA, and health-related quality
of life. Our experience in previous PA intervention studies
[47–52] leads us to believe that the aforementioned health
outcomes are more sensitive to exercise and can even be im-
proved in the absence of weight loss [53, 54]. A significant
improvement in any of these parameters with no additional
weight loss would be a plausible—and very interesting—
finding.
Conclusion
The EFIBAR study will provide new insights into the
multidimensional benefits of exercise in adults with
severe/extreme obesity following bariatric surgery. Using
a wide variety of clinical, psychological, and socio-
economic indicators, this study will compare the combi-
nation of supervised exercise and usual care with usual
care alone. We hypothesize that a 16-week exercise pro-
gram using strength and aerobic training, implemented
immediately after bariatric surgery, will improve weight
loss, body composition, cardiometabolic risk, fitness
levels, PA, health-related quality of life, and psychologi-
cal well-being, to a greater extent than the usual care. By
using cost-effectiveness and cost-utility analyses, we will
also test whether the designed intervention is not only
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Figure 2. Overview of the EFIBAR training program (formore details, see [42]). HRR: heart-rate reserve, min: minutes, reps: repetitions, RM: repetition
maximum.
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feasible and safe, but also effective and useful from an
economic standpoint.
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